Elanco Animal Health Incorporated (ELAN) Presents at Morgan Stanley 23rd Annual Global

Group 1 - Elanco Animal Health has emphasized growth, innovation, and cash as its priorities over the last 3 to 4 years, resulting in 8 consecutive quarters of growth [4] - The company has demonstrated quality growth across its core business and innovation, with positive performance in all four quadrants of its business [5] - The engagement with investors at the Morgan Stanley Global Healthcare Conference has been productive, highlighting the company's commitment to ongoing dialogue and transparency [2][3]